Andy Ka Chun Kan

Comparative Effectiveness, Safety, and Real-World Outcomes of a Nurse-Led, Protocol-Driven Penicillin Allergy Evaluation From the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI)

Andy Ka Chun Kan, Harris K S Hui, Tin Sum Li et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 43 citations

Pharmacy, Pharmacoeconomics, Allergy +8

Prospective, Multicenter, Head-to-Head Comparison Between Allergists Versus Nonallergists in Low-Risk Penicillin Allergy Delabeling: Effectiveness, Safety, and Quality of Life (HK-DADI2)

Jane C. Y. Wong, Andy Ka Chun Kan, Thomas S. H. Chik et al. · The Journal of Allergy and Clinical Immunology In Practice · 2024 · 34 citations · Full text

Life Sciences, Immunology, Internal Medicine +5

The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety

Valerie Chiang, Chinmoy Saha, Jackie S. H. Yim et al. · Annals of Allergy Asthma & Immunology · 2022 · 29 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Identifying the most at-risk age-group and longitudinal trends of drug allergy labeling amongst 7.3 million individuals in Hong Kong

Valerie Chiang, Andy Ka Chun Kan, Chinmoy Saha et al. · BMC Medicine · 2024 · 23 citations · Full text

Public Health, Preventive Medicine, Allergy +6

Chronic Spontaneous Urticaria in Hong Kong: Clinical Characteristics, Real-World Practice and Implications for COVID-19 Vaccination

Andy Ka Chun Kan, Thomas Tsz Hang Wong, Valerie Chiang et al. · Allergy Asthma and Immunology Research · 2023 · 16 citations · Full text

Medicine, Dermatology, Immunology +12